Endocrine Pancreas Flashcards
Islets of Langerhans
Clusters of cells releasing insulin, glucagon and somatostatin
What cells release glucagon, insulin, C peptide, pancreatic polypeptide and somatostatin
B-cells release insulin and C-peptide
alpha-cells release glucagon
D-cells release somatostatin
F cells secrete pancreatic polypeptide
Steps of insulin release
Glucose enters cells via GLUT-2 transporter
Glucose phosphorylated by glucokinase
G6P is oxidized which promotes ATP generation
ATP closes inward rectifying K+ channels causing depolarization
VG-Ca channels activated which initiates mobilization of insulin and C-peptide and exocytosis results
Sulfonylurea receptor
Associated with ATP-dependent K+ channels, increase insulin secretion
- causes membrane depolarization to occur more easily
- more Ca entry
- treats type II DM
Insulin receptor
Bound- insulin receptor autophosphorylates itself and phosphorylates other proteins
Insulin-receptor complex is internalized by target cells
Downregulation of receptor by insulin itself
Causes translocation of vesicles containing GLUT4 to the membrane - allowing glucose to enter cells
AMP Kinase
Activation of AMP-kinase results in GLUT4 translocation to plasma membrane
Muscle contractions stimulate this process
Therefor, doing insulin injections during exercise can cause a hypoglycemic state
Insulin stimulating factors
Increased AA, FA Glucagon Cortisol GIP K+ Vagal stimulation Sulfonylurea drugs
Insulin inhibitory factors
Fasting Exercise Somatostatin a-adrenergic agonists;norepinephrine Diazoxide (K+ channel activator which relaxes smooth muscle)
Gut hormones and insulin
Hormones such as CCK and GLP-1 that are secreted during meals help cause insulin release
If these pathways are effected, insulin release will be as well
Secretion of glucagon
Insulin inhibits glucagon production and secretion
Glucagon increases blood glucose by inhibited glycogen synthesis and activation glycogenolysis
Stimulates lipolysis in adipose tissue and skeletal muscle
Type I DM
Destruction of B-cells
Decreased utilization of ketoacids leads to diabetic ketoacidosis
Hyperkalemia (intracellular potassium is low, may or may not have high extracellular K+)
Osmotic diuresis/Glucosuria- polyurea
Type II DM
Progressive exhaustion of B-cells due to environmental factors
Patients still produce insulin
Progression of insulin resistance and type 2 DM
Reactive hyperinsulinemia
Obesity-induced insulin resistance: decreased GLUT4 uptake of glucose in response to insulin
Decreased ability of insulin to repress hepatic glucose production
Inability of insulin to repress adipose tissue uptake (via LPL) and lipolysis (via HSL) - fatty liver disease
Hyperglucagonemia
Stages of glucose/insulin levels in type 2 DM
At first, glucose looks normal but insulin must be higher to take in the glucose
Then glucose in-between or after meals is elevated
Then fasting glucose levels are elevated
Eventually beta cells will die off and patient will present more like type I diabetic (in terms of insulin release)
Treatment of type 2 DM
Insulin sensitizers like metformin
Slow absorption of CHO via a-glucosidase inhibitors or amylin analogs
Insulin secretagogues such as sulfonylurea drugs or analogs of GLP1